Recent News

By Category: Agents & Toxins

Public Health Ministry warns Thais of 17 monsoon diseases

(PattayaMail) The Public Health Ministry has expressed its concerns on people catching diseases during the wet season, while disclosing that nearly 900,000 people were found sick during the rainy season of 2012, with 764 fatalities. As Thailand has now entered the monsoon season, Dr. Pradit Sintavanarong, Minister of Public Health, has warned people to be Read More »

June 4, 2013
| Filed under North America, South Asia, Agents & Toxins, International, and Public Health
Share

New kind of antibiotic may be more effective at fighting tuberculosis, anthrax, and other diseases

(EurekAlert) Diseases such as tuberculosis, anthrax, and shigellosis — a severe food-borne illness — eventually could be treated with an entirely new and more-effective kind of antibiotic, thanks to a team of scientists led by Kenneth Keiler, an associate professor of biochemistry and molecular biology at Penn State University. In a research paper that will Read More »

June 4, 2013
| Filed under North America, Agents & Toxins, Agriculture, Public Health, and Research
Share

Protect swine herds from PED with proper biosecurity protocols

(MSUExtension) With the recent outbreak of Porcine Epidemic Diarrhea (PED) producers need to be conscious of their biosecurity protocols and methods. Strict biosecurity procedures are the first line of defense when protecting your swine herd from this disease that is new to the United States. Guidelines should be in place for cleaning and disinfection of Read More »

June 3, 2013
| Filed under North America, Agents & Toxins, Agriculture, Countermeasures, and Research
Share

Bavarian Nordic’s IMVANEX(r) Smallpox Vaccine Receives Positive Opinion From European Regulatory Authorities

(TheWallStreetJournal) Bavarian Nordic A/S (OMX:BAVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for IMVANEX(r) for active immunization against smallpox disease for the general adult population, including people with immunodeficiencies (people diagnosed with Read More »

June 3, 2013
| Filed under Europe, North America, Agents & Toxins, Countermeasures, International, Public Health, and Research
Share

Double dose of antiviral drug offers no added benefit in severe influenza

(EurekAlert) Giving double doses of the antiviral drug oseltamivir, or Tamiflu, offers no clinical or virological advantages over a standard dose for patients admitted to hospital with severe influenza infection, according to a randomised trial published today and funded by the Wellcome Trust, US National Institute of Allergy and Infectious Diseases and the Singapore National Read More »